Immunotherapy
- B2C
- Early StageStartup in initial stages
ApoVax Funding
$375K
22 rounds
MetaCyte Business Lab
ApoVax is active in the following markets / industries: biotechnology and bio pharm. The company has secured funding across 2 rounds, totaling in an amount of $375K. Their most recent funding was raised on November 27, 2012.
Funding Rounds
U
$125000U
$250000Investors of ApoVax
George Emont
